SRP3311
IL-8 (72AA) human
Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
Manufacturer: Sigma Aldrich
Synonym(S): CXCL8, NAP-1, monocyte-derived neutrophil chemotactic factor (MDNCF), neutrophil activating factor (NAF)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 μG | SRP3311-25-μG | In Stock | ₹ 39,349.50 |
SRP3311 - 25 μG
In Stock
Quantity
1
Base Price: ₹ 39,349.50
GST (18%): ₹ 7,082.91
Total Price: ₹ 46,432.41
biological source
human
recombinant
expressed in E. coli
Assay
≥98% (HPLC)≥98% (SDS-PAGE)
form
lyophilized
mol wt
8.4 kDa
packaging
pkg of 25 μg
impurities
endotoxin, tested
UniProt accession no.
P10145
shipped in
wet ice
storage temp.
−20°C
Related Products
Description
- General description: Interleukin-8 (IL-8) is a proinflammatory CXC chemokine that can signal through the C-X-C motif chemokine receptors 1 and 2 (CXCR1 and 2). It is also called as C-X-C motif chemokine ligand 8 (CXCL8).[1][2] IL-8 is secreted by monocytes and endothelial cells. The gene encoding Il-8 is localized on human chromosome 4q13.3.[3] Recombinant human IL-8 (monocyte-derived) is an 8.4kDa protein containing 72 amino acid residues.
- Biochem/physiol Actions: Interleukin-8 (IL-8) chemoattracts and activates neutrophils. It is involved in guiding neutrophils and oligodendrocytes to sites of infection. The protein also stimulates angiogenesis and tumor growth. It is also associated with inflammatory diseases.[1][2][4]
- Physical form: Lyophilized with no additives.
- Reconstitution: Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing a carrier protein (example 0.1% BSA) and store in working aliquots at -20°C to -80°C.
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
biological source: human
recombinant: expressed in E. coli
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
mol wt: 8.4 kDa
packaging: pkg of 25 μg
impurities: endotoxin, tested
UniProt accession no.: P10145
shipped in: wet ice
storage temp.: −20°C
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
mol wt:
8.4 kDa
packaging:
pkg of 25 μg
impurities:
endotoxin, tested
UniProt accession no.:
P10145
shipped in:
wet ice
storage temp.:
−20°C
biological source: human
recombinant: expressed in E. coli
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
mol wt: 18.6 kDa
packaging: pkg of 10 μg
impurities: endotoxin, tested
UniProt accession no.: P22301
shipped in: wet ice
storage temp.: __
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
mol wt:
18.6 kDa
packaging:
pkg of 10 μg
impurities:
endotoxin, tested
UniProt accession no.:
P22301
shipped in:
wet ice
storage temp.:
__
biological source: human
recombinant: expressed in E. coli
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
mol wt: 33.8 kDa
packaging: pkg of 25 μg
impurities: endotoxin, tested
UniProt accession no.: Q9H293
shipped in: wet ice
storage temp.: __
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
mol wt:
33.8 kDa
packaging:
pkg of 25 μg
impurities:
endotoxin, tested
UniProt accession no.:
Q9H293
shipped in:
wet ice
storage temp.:
__
biological source: human
recombinant: expressed in E. coli
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
mol wt: 33.6 kDa
packaging: pkg of 10 μg
impurities: endotoxin, tested
UniProt accession no.: Q9GZX6
shipped in: wet ice
storage temp.: __
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
mol wt:
33.6 kDa
packaging:
pkg of 10 μg
impurities:
endotoxin, tested
UniProt accession no.:
Q9GZX6
shipped in:
wet ice
storage temp.:
__